news
Press release
 
April 29, 2019
Corindus to Report First Quarter 2019 Financial Results on May 7, 2019

WALTHAM, MA April 29, 2019 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release first quarter 2019 financial and business results on Tuesday, May 7, 2019 after the close of the U.S. financial markets.

Mark Toland, President and Chief Executive Officer, and David Long, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date: Tuesday, May 7, 2019
Time: 4:30 p.m. EST
Toll free (U.S.): (833) 286-5802
International: (647) 689-4447
Conference ID: 5649418
Webcast (live and replay): www.corindus.com under the ‘Investor Relations’ section.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the secondgeneration robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world. For additional information, visit www.corindus.com, and follow @CorindusInc.

Media Contact:

Matter for Corindus

Jessica Wolter
T: 978-518-4536
corindus@matternow.com
https://www.matternow.com/

Investor Contact:

Lisa Wilson
In-Site Communications, Inc.
T: 917-543-9932
ir@corindus.com
 
close the window

Please complete the form below in order to download the content.






news
Press release
 
April 29, 2019
Corindus to Report First Quarter 2019 Financial Results on May 7, 2019

WALTHAM, MA April 29, 2019 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release first quarter 2019 financial and business results on Tuesday, May 7, 2019 after the close of the U.S. financial markets.

Mark Toland, President and Chief Executive Officer, and David Long, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date: Tuesday, May 7, 2019
Time: 4:30 p.m. EST
Toll free (U.S.): (833) 286-5802
International: (647) 689-4447
Conference ID: 5649418
Webcast (live and replay): www.corindus.com under the ‘Investor Relations’ section.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the secondgeneration robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world. For additional information, visit www.corindus.com, and follow @CorindusInc.

Media Contact:

Matter for Corindus

Jessica Wolter
T: 978-518-4536
corindus@matternow.com
https://www.matternow.com/

Investor Contact:

Lisa Wilson
In-Site Communications, Inc.
T: 917-543-9932
ir@corindus.com
 
close the window

Please complete the form below in order to download the content.







close the window

Please complete the form below in order to download the content.







close the window

Please fill out this brief form to subscribe to our email newsletter.





close the window

Please complete the form below and a member of our Clinical team will contact you.






close the window

Please complete the form below in order to download the content.







close the window